Cogent Biosciences Inc
Company Profile
Business description
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling.Unum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immunotherapy products designed to harness the power of a patient's immune system to cure cancer.
Contact
275 Wyman Street
3rd Floor
Waltham MA 02451
USAT: +1 617 945-5576
E: stephanie@sternir.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2023
Employees
138
Stocks News & Analysis
stocks
Despite rally this A-REIT remains undervalued
stocks
We advise waiting for a pullback before investing in the world's biggest company
stocks
7 charts on the AI stock boom one year after ChatGPT’s launch
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 7,336.10 | 51.00 | 0.70% |
| CAC 40 | 7,332.59 | 13.56 | -0.18% |
| DAX 40 | 16,404.76 | 7.24 | 0.04% |
| Dow JONES (US) | 36,204.44 | 41.06 | -0.11% |
| FTSE 100 | 7,512.96 | 16.39 | -0.22% |
| HKSE | 16,646.05 | 184.25 | -1.09% |
| NASDAQ | 14,185.49 | 119.54 | -0.84% |
| Nikkei 225 | 33,231.27 | 200.24 | -0.60% |
| NZX 50 Index | 11,328.03 | 39.78 | -0.35% |
| S&P 500 | 4,569.78 | 24.85 | -0.54% |
| S&P/ASX 200 | 7,124.70 | 51.50 | 0.73% |
| SSE Composite Index | 3,022.91 | 8.72 | -0.29% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Pilbara Minerals Ltd PLS | 3.53 | 0.08 | -2.22% |
| Telstra Group Ltd TLS | 3.79 | 0.00 | 0.00% |
| Transurban Group TCL | 12.97 | 0.05 | 0.39% |
| South32 Ltd S32 | 3.12 | 0.03 | 0.97% |
| Evolution Mining Ltd EVN | 4.14 | 0.10 | 2.48% |
| Scentre Group SCG | 2.71 | 0.04 | 1.50% |
| Insurance Australia Group Ltd IAG | 5.83 | 0.11 | -1.85% |
| Santos Ltd STO | 6.82 | 0.08 | -1.16% |
| Incitec Pivot Ltd IPL | 2.87 | 0.04 | -1.37% |
| BHP Group Ltd BHP | 47.14 | 0.80 | 1.73% |